Is a complete DMII research report available?

No complete published report is available for Drugs Made In America Acquisition II Corp. (DMII) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Drugs Made In America Acquisition II Corp. (DMII)

NASDAQ: DMII · USD

$10.1

+0.01 (+0.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first DMII analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	644.6M
Net income (ttm)	8.6M
EPS (ttm)	$0.21
Shares out	63.7M
P/E (trailing)	47.7x
Volume	55,707

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 8.6M
EPS (ttm): $0.21
P/E (trailing): 47.7x
Market cap: 644.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AXP	American Express Company	223.9B	20.1x	3.2x	11.9%	+13.2%	+7.8%	Reduce
BAC	Bank of America Corporation	428.6B	14.1x	3.8x	—	+5.6%	+29.4%	Reduce
BK	The Bank of New York Mellon Corporation	—	—	—	—	—	—	Reduce

All DMII indicators

Market & fundamental data

Available fields

124

Groups with data

Currency

USD

Showing 124 of 124 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002040475
Company name	Drugs Made In America Acquisition II Corp.
Country	United States
Country code	US
Cusip	G2851K104
Enterprise value	$644.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Shell Companies
IPO Date	2025-09-25
Isin	KYG2851K1040
Last refreshed	2026-07-30
Market cap	$644.6M
Market cap category	Small-Cap
Price	$10.12
Price currency	USD
Sector	Financials
Sector PE	17.17
Sector PE Fwd	14.5
Sic	6770
Symbol	DMII

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.33%
EV Earnings	75.03x
P/E ratio	47.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$8.6M
ROCE	-0.26

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$509.7M
Cash	$347,720
Current Assets	$351,761
Current Liabilities	$666,285
Debt	$450,000
Equity	$-17.8M
Liabilities	$527.5M
Long Term Assets	$509.4M
Long Term Liabilities	$526.9M
Net Cash	$-102,280
Net Cash By Market Cap	$-0.02
Tangible Book Value	$-17.8M
Tangible Book Value Per Share	$-0.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.53
Net Working Capital	$-212,244
Quick ratio	0.52
Working Capital	$-314,524

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	10.08
All Time High	10.2
All Time High Change	-0.78%
All Time High Date	2026-07-28
All Time Low	9.86
All Time Low Change	2.64%
All Time Low Date	2025-12-04
ATR	0.02
Beta1y	0.02
Ch YTD	2.22
High	10.14
High52	10.2
High52 Date	2026-07-28
High52ch	-0.78%
Low	10.11
Low52	9.86
Low52 Date	2025-12-04
Low52ch	2.64%
Ma50ch	0.44%
RSI	64.78
RSI Monthly	0
RSI Weekly	74.22
Sharpe ratio	-0.01x
Sortino ratio	3.16
Tr YTD	2.22
Tr1m	0.7%
Tr1w	0.3%
Tr3m	1.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-1.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,258,334%
Float Percent	78.9%
Net Borrowing	-83,781
Shares Insiders	10.57%
Shares Institutions	70.24%
Shares Out	63,700,000
Shares Qo Q	0%
Short Float	0.09%
Short Ratio	0.4
Short Shares	0.07

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	64,768x
Bv Per Share	-0.28
Ch1m	0.7
Ch1w	0.3
Ch3m	1.1
Ch6m	1.61
Change	0.1%
Change From Open	-0.2
Close	10.11
Days Gap	0.3
Dollar Volume	563,754.8
EBIT	$-1.3M
EPS	$0.21
F Score	1
Financing CF	501,451,419
Fiscal Year End	December
Founded	2,024
Investing CF	-500,000,000
Ipr	1.1
Is Primary Listing	1
Is Spac	Yes
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-04-15
Ma150	10
Ma150ch	1.2%
Ma20	10.09
Ma20ch	0.27%
Net CF	340,729
Open	10.14
Optionable	No
Position In Range	33.33
Post Close	10.12
Postmarket Change Percent	0.1
Postmarket Price	$10.13
Price Date	2026-07-29
Relative Volume	0.86x
Tr6m	1.61%
Us State	New York
Volume	55,707

Drugs Made In America Acquisition II Corp. (DMII)

Coverage state: Market snapshot only — no published research

Generate the first DMII analysis

Price

Financial snapshot

Fair-value bridge

Latest news · DMII

Valuation

Balance sheet

Trading

Next earnings

Sector percentile context

All DMII indicators

Profile and market data

Valuation

Profitability

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on DMII

Frequently asked questions